Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
59 studies found for:    parkinson's disease AND baylor
Show Display Options
RSS Create an RSS feed from your search for:
parkinson's disease AND baylor
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  MER Versus MRI Guidance DBS in Parkinson's Disease
Condition: Idiopathic Parkinson's Disease (PD)
Intervention:
2 Completed
Has Results
Amitiza in Constipation Associated With PD (Parkinson's Disease)
Condition: Parkinson's Disease
Intervention: Drug: LUBIPROSTONE
3 Completed Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD)
Condition: Parkinson Disease
Intervention: Drug: sodium oxybate
4 Completed Namenda (Memantine) for Non-Motor Symptoms in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Memantine;   Drug: placebo
5 Withdrawn Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: acamprosate
6 Completed Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Zelapar
7 Completed Parcopa Versus Carbidopa-Levodopa in a Single Dose Cross-Over Comparison Study
Condition: Parkinson's Disease
Interventions: Drug: Parcopa;   Drug: carbidopa-levodopa
8 Completed Flu-Like Symptoms as a Complication of Botulinum Toxin Therapy
Condition: Flu-like Symptoms
Intervention:
9 Completed Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations
Condition: Parkinson's Disease
Interventions: Drug: rasagiline mesylate;   Drug: 1.0 mg rasagiline mesylate;   Other: Placebo
10 Recruiting Study of Urate Elevation in Parkinson's Disease, Phase 3
Condition: Parkinson's Disease
Interventions: Drug: Inosine;   Drug: Placebo
11 Recruiting OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Conditions: Accidental Falls;   Fall Due to Loss of Equilibrium;   High Risk of Falls Due to Mobility Limitation;   Diabetes;   Arthritis;   Cancer;   Peripheral Arterial Disease;   Parkinson's Disease;   End Stage Renal Failure on Dialysis
Interventions: Device: AFO;   Other: Control
12 Recruiting SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)
Condition: Parkinson's Disease Dementia (PDD)
Interventions: Drug: SYN120;   Drug: Placebo
13 Active, not recruiting Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes
Condition: Parkinson Disease
Intervention: Other: Virtual Visits
14 Completed Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)
Condition: Parkinson's Disease
Interventions: Drug: PYM50028;   Drug: Placebo
15 Recruiting Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
Condition: Parkinson Disease
Interventions: Drug: Placebo;   Drug: PF-06649751 low dose;   Drug: PF-06649751 middle dose level 1;   Drug: PF-06649751 middle dose level 2;   Drug: PF-06649751 high dose
16 Completed
Has Results
An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: IPX066
17 Completed
Has Results
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: placebo;   Drug: IPX066
18 Completed Parkinson's Research: The Organized Genetics Initiative
Condition: Parkinson Disease
Intervention:
19 Recruiting Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
Condition: Parkinson Disease
Intervention: Drug: Datscan and AV-133
20 Enrolling by invitation A Longitudinal Observational Follow-up of the PRECEPT Study Cohort
Condition: Parkinson Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.